Promontory Therapeutics
PrivateLast Round
Series A
Dec 14, 2021
Total Funding Raised
$37M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Promontory Therapeutics is a clinical-stage biotechnology company that develops small-molecule immunotherapies for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Promontory Therapeutics Comparables
Compare Promontory Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pimera Therapeutics | 81% | |
| Johnson & Johnson | 78% | |
| Zenith Capital Corp. | 73% |
Promontory Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 14, 2021 | ||||
| VC Round | Aug 26, 2020 | ||||
| VC Round | Nov 8, 2018 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 47% MoM.
- Jun 18, 2026
Monthly visitors grew 55% MoM, reaching 2.3K.
Promontory Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Promontory Therapeutics's valuation, stock price, and market status.
Is Promontory Therapeutics a public or private company?
Promontory Therapeutics is a private company.
What is the current stock price of Promontory Therapeutics?
Promontory Therapeutics is a private company, so its shares have no public market price. Caplight tracks Promontory Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Promontory Therapeutics worth (valuation)?
Valuation information for Promontory Therapeutics is not publicly available.
Can I buy Promontory Therapeutics stock?
Promontory Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Promontory Therapeutics's last funding round?
Promontory Therapeutics's most recent funding round was Series A on December 14, 2021.
Who are the main investors in Promontory Therapeutics?
Investor information for Promontory Therapeutics is not publicly disclosed.
Will Promontory Therapeutics IPO soon?
No public IPO plans have been announced for Promontory Therapeutics.
How can I track Promontory Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Promontory Therapeutics's shares on secondary markets.